GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...

Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...

Elon Musk has dished the secrets behind his recent weight loss transformation.

Semaglutide and Tirzepatide, both FDA-approved medications, are glucagon-like peptide-1 (GLP-1) receptor agonists that have gained recognition for their efficacy in supporting significant weight loss.

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...